Occult papillary thyroid carcinoma in postmortem species: prevalence at autopsy
- PMID: 15742259
- DOI: 10.1016/j.amjoto.2004.08.003
Occult papillary thyroid carcinoma in postmortem species: prevalence at autopsy
Abstract
Objective: The purpose of this study was to determine the prevalence of occult papillary thyroid cancer (OPTC) in a sample of cadavers from Guatemala, a country in Central America.
Study design and setting: This was a cross-sectional study of cadaver samples. We analyzed 150 glands that were removed during autopsy from 150 cadavers (34 women and 116 men) who were admitted to the morgue of the Judicial Bureau between January and March 2000.
Results: A total of 17 glands showed macroscopic evidence of disease, but only 3 glands (1 female and 2 males) showed microscopic evidence of malignancy. This corresponded to a 2% prevalence rate (range, 0.4-5.7%). The sex prevalence of OPTC was 2.9% (range, 0.07-15%) for females and 1.7% (range, 0.2-6.1%) for males. No significant difference was noted ( P = .47, exact unconditional test). The male-to-female ratio was 1:1.7.
Conclusion: We concluded that the prevalence of OPTC in Guatemala is low but comparable to literature reports. Occult papillary thyroid carcinoma appears to have no sex predilection as opposed to the clinically evident papillary thyroid carcinoma, which develops more commonly in females.
Significance: Occult papillary thyroid carcinoma is a much more common pathology than clinically evident thyroid cancer, and the clinical implications still need to be determined.
Similar articles
-
Occult papillary thyroid carcinoma: prevalence at autopsy in Turkish people.Eur J Cancer Prev. 2011 Jul;20(4):308-12. doi: 10.1097/CEJ.0b013e32834473dc. Eur J Cancer Prev. 2011. PMID: 21464719
-
Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina.Cancer. 1989 Jul 15;64(2):547-51. doi: 10.1002/1097-0142(19890715)64:2<547::aid-cncr2820640232>3.0.co;2-n. Cancer. 1989. PMID: 2736500
-
Occult papillary thyroid carcinoma in the young and the aged.Cancer. 1984 Apr 15;53(8):1790-2. doi: 10.1002/1097-0142(19840415)53:8<1790::aid-cncr2820530831>3.0.co;2-9. Cancer. 1984. PMID: 6697317
-
Controversies in papillary microcarcinoma of the thyroid.Endocr Pathol. 2003 Fall;14(3):183-91. doi: 10.1007/s12022-003-0011-5. Endocr Pathol. 2003. PMID: 14586064 Review.
-
The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma.Cancer. 1989 Nov 1;64(9):1888-93. doi: 10.1002/1097-0142(19891101)64:9<1888::aid-cncr2820640922>3.0.co;2-c. Cancer. 1989. PMID: 2676140 Review.
Cited by
-
Managing thyroid microcarcinomas.Yonsei Med J. 2012 Jan;53(1):1-14. doi: 10.3349/ymj.2012.53.1.1. Yonsei Med J. 2012. PMID: 22187228 Free PMC article. Review.
-
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.Med Oncol. 2010 Sep;27(3):756-9. doi: 10.1007/s12032-009-9281-1. Epub 2009 Aug 6. Med Oncol. 2010. PMID: 19657751
-
Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis.Am J Surg. 2010 Oct;200(4):454-61. doi: 10.1016/j.amjsurg.2009.11.008. Epub 2010 Jun 18. Am J Surg. 2010. PMID: 20561605 Free PMC article.
-
Is papillary thyroid microcarcinoma an indolent tumor?: A retrospective study on 280 cases treated with radioiodine.Medicine (Baltimore). 2016 Oct;95(40):e5067. doi: 10.1097/MD.0000000000005067. Medicine (Baltimore). 2016. PMID: 27749574 Free PMC article.
-
Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas.Yonsei Med J. 2008 Oct 31;49(5):748-56. doi: 10.3349/ymj.2008.49.5.748. Yonsei Med J. 2008. PMID: 18972595 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical